Midtown drug startup raises $13M to capitalize on opioid-alternative boom

Crain's New York Business

Dec 22, 2024

Upper East Side-based startup Spine BioPharma has raised $13.5 million in equity and debt from undisclosed investors, selling both a stake in the company and bonds to be repaid dow…